Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 61

1.

Feasibility of hospital-initiated non-facilitator assisted advance care planning documentation for patients with palliative care needs.

Kok M, van der Werff GFM, Geerling JI, Ruivenkamp J, Groothoff W, van der Velden AWG, Thoma M, Talsma J, Costongs LGP, Gans ROB, de Graeff P, Reyners AKL.

BMC Palliat Care. 2018 May 24;17(1):79. doi: 10.1186/s12904-018-0331-3.

2.

Effectiveness of general practitioner online training and an information booklet for parents on antibiotic prescribing for children with respiratory tract infection in primary care: a cluster randomized controlled trial.

Dekker ARJ, Verheij TJM, Broekhuizen BDL, Butler CC, Cals JWL, Francis NA, Little P, Sanders EAM, Yardley L, Zuithoff NPA, van der Velden AW.

J Antimicrob Chemother. 2018 May 1;73(5):1416-1422. doi: 10.1093/jac/dkx542.

PMID:
29438547
3.

CCR2+ Inflammatory Monocytes Are Recruited to Yersinia pseudotuberculosis Pyogranulomas and Dictate Adaptive Responses at the Expense of Innate Immunity during Oral Infection.

Zhang Y, Khairallah C, Sheridan BS, van der Velden AWM, Bliska JB.

Infect Immun. 2018 Feb 20;86(3). pii: e00782-17. doi: 10.1128/IAI.00782-17. Print 2018 Mar.

PMID:
29263104
4.

Neutrophil Recovery in Breast Cancer Patients Receiving Docetaxel-Containing Chemotherapy with and without Granulocyte Colony-Stimulating Factor Prophylaxis.

Aarts MJ, Vriens BE, de Boer M, Peters FP, Mandigers CM, Dercksen MW, Stouthard JM, Tol J, van Warmerdam LJ, van de Wouw AJ, Jacobs EM, van der Rijt CCD, Smilde TJ, van der Velden AW, Peer N, Tjan-Heijnen VCG.

Oncology. 2017;93(5):323-328. doi: 10.1159/000479067. Epub 2017 Aug 22.

PMID:
28848182
5.

Web-Based Tailored Psychoeducation for Breast Cancer Patients at the Onset of the Survivorship Phase: A Multicenter Randomized Controlled Trial.

Admiraal JM, van der Velden AWG, Geerling JI, Burgerhof JGM, Bouma G, Walenkamp AME, de Vries EGE, Schröder CP, Reyners AKL.

J Pain Symptom Manage. 2017 Oct;54(4):466-475. doi: 10.1016/j.jpainsymman.2017.07.009. Epub 2017 Jul 13.

PMID:
28711750
6.

Antibiotic prescribing during office hours and out-of-hours: a comparison of quality and quantity in primary care in the Netherlands.

Debets VE, Verheij TJ, van der Velden AW; SWAB’s Working Group on Surveillance of Antimicrobial Use.

Br J Gen Pract. 2017 Mar;67(656):e178-e186. doi: 10.3399/bjgp17X689641.

7.

Antibiotic management of children with infectious diseases in Dutch Primary Care.

Dekker ARJ, Verheij TJM, van der Velden AW.

Fam Pract. 2017 Apr 1;34(2):169-174. doi: 10.1093/fampra/cmw125.

PMID:
28122841
8.

Contribution of Asparagine Catabolism to Salmonella Virulence.

McLaughlin PA, McClelland M, Yang HJ, Porwollik S, Bogomolnaya L, Chen JS, Andrews-Polymenis H, van der Velden AW.

Infect Immun. 2017 Jan 26;85(2). pii: e00740-16. doi: 10.1128/IAI.00740-16. Print 2017 Feb.

9.

Salmonella Gives MARCH(ing) Orders to MHC-II.

McLaughlin PA, van der Velden AWM.

Cell Host Microbe. 2016 Nov 9;20(5):551-552. doi: 10.1016/j.chom.2016.10.019.

10.

Antibiotic preferences for childhood pneumonia vary by physician type and European region.

Bielicki JA, Barker CI, van der Velden AW, Sharland M, van Esso D, Hadjipanayis A, Del Torso S, Grossman Z.

ERJ Open Res. 2016 Apr 29;2(2). pii: 00001-2016. eCollection 2016 Apr.

11.

Usefulness of quality indicators for antibiotic use: case study for the Netherlands.

van der Velden AW, Roukens M, van de Garde E, Lourens M, Natsch S; SWAB's working group on surveillance of antimicrobial use.

Int J Qual Health Care. 2016 Dec 1;28(6):838-842. doi: 10.1093/intqhc/mzw117.

PMID:
27664820
12.

Angiotensin II-Receptor Inhibition With Candesartan to Prevent Trastuzumab-Related Cardiotoxic Effects in Patients With Early Breast Cancer: A Randomized Clinical Trial.

Boekhout AH, Gietema JA, Milojkovic Kerklaan B, van Werkhoven ED, Altena R, Honkoop A, Los M, Smit WM, Nieboer P, Smorenburg CH, Mandigers CM, van der Wouw AJ, Kessels L, van der Velden AW, Ottevanger PB, Smilde T, de Boer J, van Veldhuisen DJ, Kema IP, de Vries EG, Schellens JH.

JAMA Oncol. 2016 Aug 1;2(8):1030-7. doi: 10.1001/jamaoncol.2016.1726.

PMID:
27348762
13.

Discrepancies between qualitative and quantitative evaluation of randomised controlled trial results: achieving clarity through mixed methods triangulation.

Tonkin-Crine S, Anthierens S, Hood K, Yardley L, Cals JW, Francis NA, Coenen S, van der Velden AW, Godycki-Cwirko M, Llor C, Butler CC, Verheij TJ, Goossens H, Little P; GRACE INTRO/CHAMP consortium.

Implement Sci. 2016 May 12;11:66. doi: 10.1186/s13012-016-0436-0.

14.

Melphalan, prednisone, and lenalidomide versus melphalan, prednisone, and thalidomide in untreated multiple myeloma.

Zweegman S, van der Holt B, Mellqvist UH, Salomo M, Bos GM, Levin MD, Visser-Wisselaar H, Hansson M, van der Velden AW, Deenik W, Gruber A, Coenen JL, Plesner T, Klein SK, Tanis BC, Szatkowski DL, Brouwer RE, Westerman M, Leys MR, Sinnige HA, Haukås E, van der Hem KG, Durian MF, Mattijssen EV, van de Donk NW, Stevens-Kroef MJ, Sonneveld P, Waage A.

Blood. 2016 Mar 3;127(9):1109-16. doi: 10.1182/blood-2015-11-679415. Epub 2016 Jan 22.

15.

Asparagine deprivation mediated by Salmonella asparaginase causes suppression of activation-induced T cell metabolic reprogramming.

Torres A, Luke JD, Kullas AL, Kapilashrami K, Botbol Y, Koller A, Tonge PJ, Chen EI, Macian F, van der Velden AW.

J Leukoc Biol. 2016 Feb;99(2):387-98. doi: 10.1189/jlb.4A0615-252R. Epub 2015 Oct 23.

16.

Improving antibiotic prescribing quality by an intervention embedded in the primary care practice accreditation: the ARTI4 randomized trial.

van der Velden AW, Kuyvenhoven MM, Verheij TJ.

J Antimicrob Chemother. 2016 Jan;71(1):257-63. doi: 10.1093/jac/dkv328. Epub 2015 Oct 21.

PMID:
26490015
17.

CCR2+ Inflammatory Dendritic Cells and Translocation of Antigen by Type III Secretion Are Required for the Exceptionally Large CD8+ T Cell Response to the Protective YopE69-77 Epitope during Yersinia Infection.

Zhang Y, Tam JW, Mena P, van der Velden AW, Bliska JB.

PLoS Pathog. 2015 Oct 15;11(10):e1005167. doi: 10.1371/journal.ppat.1005167. eCollection 2015 Oct.

18.

Inappropriate antibiotic prescription for respiratory tract indications: most prominent in adult patients.

Dekker AR, Verheij TJ, van der Velden AW.

Fam Pract. 2015 Aug;32(4):401-7. doi: 10.1093/fampra/cmv019. Epub 2015 Apr 24.

PMID:
25911505
19.

The standardised mortality ratio: the proper quality indicator in acute leukaemia?

Saes L, Peters WG, Schaafsma R, van Spronsen DJ, van der Velden AW, van den Bosch WF, Meijer E.

Neth J Med. 2015 Mar;73(3):119-23.

20.

Persistent salmonellosis causes pancreatitis in a murine model of infection.

DelGiorno KE, Tam JW, Hall JC, Thotakura G, Crawford HC, van der Velden AW.

PLoS One. 2014 Apr 9;9(4):e92807. doi: 10.1371/journal.pone.0092807. eCollection 2014.

21.

CD11b+ Ly6Chi Ly6G- immature myeloid cells recruited in response to Salmonella enterica serovar Typhimurium infection exhibit protective and immunosuppressive properties.

Tam JW, Kullas AL, Mena P, Bliska JB, van der Velden AW.

Infect Immun. 2014 Jun;82(6):2606-14. doi: 10.1128/IAI.01590-13. Epub 2014 Apr 7.

22.

Antibiotic use in Dutch primary care: relation between diagnosis, consultation and treatment.

van den Broek d'Obrenan J, Verheij TJ, Numans ME, van der Velden AW.

J Antimicrob Chemother. 2014 Jun;69(6):1701-7. doi: 10.1093/jac/dku005. Epub 2014 Feb 6.

PMID:
24508898
23.

Cystitis: antibiotic prescribing, consultation, attitudes and opinions.

Willems CS, van den Broek D'Obrenan J, Numans ME, Verheij TJ, van der Velden AW.

Fam Pract. 2014 Apr;31(2):149-55. doi: 10.1093/fampra/cmt077. Epub 2013 Dec 7.

PMID:
24317602
24.

Sore throat: effective communication delivers improved diagnosis, enhanced self-care and more rational use of antibiotics.

van der Velden AW, Bell J, Sessa A, Duerden M, Altiner A.

Int J Clin Pract Suppl. 2013 Nov;(180):10-6. doi: 10.1111/ijcp.12336.

PMID:
24238425
25.

Evaluation of a web-based intervention to reduce antibiotic prescribing for LRTI in six European countries: quantitative process analysis of the GRACE/INTRO randomised controlled trial.

Yardley L, Douglas E, Anthierens S, Tonkin-Crine S, O'Reilly G, Stuart B, Geraghty AW, Arden-Close E, van der Velden AW, Goosens H, Verheij TJ, Butler CC, Francis NA, Little P; GRACE consortium.

Implement Sci. 2013 Nov 15;8:134. doi: 10.1186/1748-5908-8-134.

26.

Influenza vaccination coverage in patients treated with chemotherapy: current clinical practice.

Wumkes ML, van der Velden AM, van der Velden AW, Stouthard JM, Nijziel MR, Westerman M, Beeker A, Meerveld-Eggink A, Rijkers GT, Biesma DH.

Neth J Med. 2013 Nov;71(9):472-7.

27.

Serum antibody response to influenza virus vaccination during chemotherapy treatment in adult patients with solid tumours.

Wumkes ML, van der Velden AM, Los M, Leys MB, Beeker A, Nijziel MR, van der Velden AW, Westerman M, Meerveld-Eggink A, Rimmelzwaan GF, Rijkers GT, Biesma DH.

Vaccine. 2013 Dec 16;31(52):6177-84. doi: 10.1016/j.vaccine.2013.10.053. Epub 2013 Oct 29.

PMID:
24176495
28.

Cost effectiveness of primary pegfilgrastim prophylaxis in patients with breast cancer at risk of febrile neutropenia.

Aarts MJ, Grutters JP, Peters FP, Mandigers CM, Dercksen MW, Stouthard JM, Nortier HJ, van Laarhoven HW, van Warmerdam LJ, van de Wouw AJ, Jacobs EM, Mattijssen V, van der Rijt CC, Smilde TJ, van der Velden AW, Temizkan M, Batman E, Muller EW, van Gastel SM, Joore MA, Borm GF, Tjan-Heijnen VC.

J Clin Oncol. 2013 Dec 1;31(34):4283-9. doi: 10.1200/JCO.2012.48.3644. Epub 2013 Oct 28.

PMID:
24166522
29.

Primary granulocyte colony-stimulating factor prophylaxis during the first two cycles only or throughout all chemotherapy cycles in patients with breast cancer at risk for febrile neutropenia.

Aarts MJ, Peters FP, Mandigers CM, Dercksen MW, Stouthard JM, Nortier HJ, van Laarhoven HW, van Warmerdam LJ, van de Wouw AJ, Jacobs EM, Mattijssen V, van der Rijt CC, Smilde TJ, van der Velden AW, Temizkan M, Batman E, Muller EW, van Gastel SM, Borm GF, Tjan-Heijnen VC.

J Clin Oncol. 2013 Dec 1;31(34):4290-6. doi: 10.1200/JCO.2012.44.6229. Epub 2013 Apr 29.

PMID:
23630211
30.

Patient selection for therapy reduction after long-term daily proton pump inhibitor treatment for gastro-oesophageal reflux disease: trial and error.

van der Velden AW, de Wit NJ, Quartero AO, Grobbee DE, Numans ME.

Digestion. 2013;87(2):85-90. doi: 10.1159/000345144. Epub 2013 Jan 25.

PMID:
23364219
31.

L-asparaginase II produced by Salmonella typhimurium inhibits T cell responses and mediates virulence.

Kullas AL, McClelland M, Yang HJ, Tam JW, Torres A, Porwollik S, Mena P, McPhee JB, Bogomolnaya L, Andrews-Polymenis H, van der Velden AW.

Cell Host Microbe. 2012 Dec 13;12(6):791-8. doi: 10.1016/j.chom.2012.10.018.

32.

Effectiveness of physician-targeted interventions to improve antibiotic use for respiratory tract infections.

van der Velden AW, Pijpers EJ, Kuyvenhoven MM, Tonkin-Crine SK, Little P, Verheij TJ.

Br J Gen Pract. 2012 Dec;62(605):e801-7. doi: 10.3399/bjgp12X659268. Review.

33.

Salmonella "sops" up a preferred electron receptor in the inflamed intestine.

Bliska JB, van der Velden AW.

MBio. 2012 Aug 14;3(4):e00226-12. doi: 10.1128/mBio.00226-12. Print 2012.

34.

Phenotypic, morphological, and functional heterogeneity of splenic immature myeloid cells in the host response to tularemia.

Rasmussen JW, Tam JW, Okan NA, Mena P, Furie MB, Thanassi DG, Benach JL, van der Velden AW.

Infect Immun. 2012 Jul;80(7):2371-81. doi: 10.1128/IAI.00365-12. Epub 2012 Apr 23.

35.

Response to influenza virus vaccination during chemotherapy in patients with breast cancer.

Meerveld-Eggink A, de Weerdt O, van der Velden AM, Los M, van der Velden AW, Stouthard JM, Nijziel MR, Westerman M, Beeker A, van Beek R, Rimmelzwaan GF, Rijkers GT, Biesma DH.

Ann Oncol. 2011 Sep;22(9):2031-5. doi: 10.1093/annonc/mdq728. Epub 2011 Feb 8.

PMID:
21303799
36.

[Paraneoplastic pemphigus in a patient with non-Hodgkin lymphoma].

Wind LJ, van der Velden AW, Diercks GF, Pas HH, Jonkman MF.

Ned Tijdschr Geneeskd. 2010;154:A2183. Dutch.

PMID:
21176265
37.

Intravascular lymphoma as an unusual cause of multifocal cerebral infarctions discovered on FDG-PET/CT.

Boslooper K, Dijkhuizen D, van der Velden AW, Dal M, Meilof JF, Hoogenberg K.

Neth J Med. 2010 Jun;68(6):261-4.

38.

Visible fluorescence detection of type III protein secretion from bacterial pathogens.

Yount JS, Tsou LK, Dossa PD, Kullas AL, van der Velden AW, Hang HC.

J Am Chem Soc. 2010 Jun 23;132(24):8244-5. doi: 10.1021/ja102257v.

39.

Pharmacological dependency in chronic treatment of gastroesophageal reflux disease: a randomized controlled clinical trial.

van der Velden AW, de Wit NJ, Quartero AO, Grobbee DE, Numans ME.

Digestion. 2010;81(1):43-52. doi: 10.1159/000236025. Epub 2009 Dec 22.

PMID:
20029208
40.

Early onset of renal cancer in a family with Birt-Hogg-Dubé syndrome.

Kluijt I, de Jong D, Teertstra HJ, Axwijk PH, Gille JJ, Bell K, van Rens A, van der Velden AW, Middelton L, Horenblas S.

Clin Genet. 2009 Jun;75(6):537-43. doi: 10.1111/j.1399-0004.2009.01159.x. Epub 2009 Mar 23.

PMID:
19320655
41.

Recruitment of Rab27a to phagosomes controls microbial antigen cross-presentation by dendritic cells.

Kim SH, Visser A, Cruijsen C, van der Velden AW, Boes M.

Infect Immun. 2008 Nov;76(11):5373-80. doi: 10.1128/IAI.01044-08. Epub 2008 Sep 8.

42.

Maintenance treatment for GERD: residual symptoms are associated with psychological distress.

van der Velden AW, de Wit NJ, Quartero AO, Grobbee DE, Numans ME.

Digestion. 2008;77(3-4):207-13. doi: 10.1159/000143796. Epub 2008 Jul 10.

PMID:
18617743
43.

Down-modulation of TCR expression by Salmonella enterica serovar Typhimurium.

van der Velden AW, Dougherty JT, Starnbach MN.

J Immunol. 2008 Apr 15;180(8):5569-74.

44.

Mistaken identity of widely used esophageal adenocarcinoma cell line TE-7.

Boonstra JJ, van der Velden AW, Beerens EC, van Marion R, Morita-Fujimura Y, Matsui Y, Nishihira T, Tselepis C, Hainaut P, Lowe AW, Beverloo BH, van Dekken H, Tilanus HW, Dinjens WN.

Cancer Res. 2007 Sep 1;67(17):7996-8001.

45.

Mechanism-based probe for the analysis of cathepsin cysteine proteases in living cells.

Hang HC, Loureiro J, Spooner E, van der Velden AW, Kim YM, Pollington AM, Maehr R, Starnbach MN, Ploegh HL.

ACS Chem Biol. 2006 Dec 20;1(11):713-23.

PMID:
17184136
46.

Salmonella inhibit T cell proliferation by a direct, contact-dependent immunosuppressive effect.

van der Velden AW, Copass MK, Starnbach MN.

Proc Natl Acad Sci U S A. 2005 Dec 6;102(49):17769-74. Epub 2005 Nov 23.

47.

Activation of bone marrow-resident memory T cells by circulating, antigen-bearing dendritic cells.

Cavanagh LL, Bonasio R, Mazo IB, Halin C, Cheng G, van der Velden AW, Cariappa A, Chase C, Russell P, Starnbach MN, Koni PA, Pillai S, Weninger W, von Andrian UH.

Nat Immunol. 2005 Oct;6(10):1029-37. Epub 2005 Sep 11.

48.

Frequent loss of the AXIN1 locus but absence of AXIN1 gene mutations in adenocarcinomas of the gastro-oesophageal junction with nuclear beta-catenin expression.

Koppert LB, van der Velden AW, van de Wetering M, Abbou M, van den Ouweland AM, Tilanus HW, Wijnhoven BP, Dinjens WN.

Br J Cancer. 2004 Feb 23;90(4):892-9.

49.

Salmonella rapidly kill dendritic cells via a caspase-1-dependent mechanism.

van der Velden AW, Velasquez M, Starnbach MN.

J Immunol. 2003 Dec 15;171(12):6742-9.

50.

Ribosomal scanning on the highly structured insulin-like growth factor II-leader 1.

van der Velden AW, van Nierop K, Voorma HO, Thomas AA.

Int J Biochem Cell Biol. 2002 Mar;34(3):286-97.

PMID:
11849996

Supplemental Content

Loading ...
Support Center